Report Overview

The growth of the pharmaceutical drug delivery market can be attributed to growing healthcare expenditure and government support to research and development in arena of innovative drug delivery. Moreover, the growing awareness regarding the benefits of pharmaceutical drug delivery systems coupled with the progress in demand for biologics and biosimilars has further augmented the growth rate of the market.

Global Pharmaceutical Drug Delivery Market - Market Trends & Forecast Report 2028

The global pharmaceutical drug delivery market was worth USD 1,650.4 billion in 2021, and it is further projected to reach USD 2,433.7 billion by 2028, at a CAGR of 5.8% during 2022-2028 (forecast period). The growth of the pharmaceutical drug delivery market can be attributed to growing healthcare expenditure and government support for research and development in the arena of innovative drug delivery. Moreover, the growing awareness regarding the benefits of pharmaceutical drug delivery systems coupled with the progress in demand for biologics and biosimilars has further augmented the growth rate of the market.

Pharmaceutical Drug Delivery Overview

Pharmaceutical drug delivery is a formulation or device used to administer the therapeutic substance or drug into the body. The pharmaceutical drug delivery system works by delivering a therapeutic substance or drug to specific body segments through a different medium that can be controlled by either physiological or chemical triggers for the controlled delivery of the drug. The Pharmaceutical Drug Delivery system is used to improve the efficacy and safety of the drug administered by controlling the time, rate, and place of the drug release in the body.

Global Pharmaceutical Drug Delivery Market Trends

Growth Driver

Growing Health Expenditure and Government Support for Research in the Arena of Drug Delivery

There has been an increment in the prevalence of numerous chronic diseases, requiring the use of pharmaceutical drug delivery systems. This has compelled governments worldwide to augment their healthcare expenditure and governmental support for research in the drug delivery arena, which is fueling the growth of the pharmaceutical drug delivery market over the forecast period. According to OECD Health Statistics 2022, the OECD health spending as a part of GDP for 17 countries increased from 8.7% in 2018 to 9.7% in 2020.

Furthermore, the pharmaceutical drug delivery system is well-recognized for having the ability to deliver a drug to a definite site in the body. Thus, this growing awareness regarding the benefits of pharmaceutical drug delivery systems has resulted in a sudden spike in the shifting of patients towards advanced drug delivery systems worldwide. These aspects lead to the growth of the pharmaceutical drug delivery market.

Growth in Demand for Biologics and Biosimilars

A biologic is a medication obtained from a living source, while a biosimilar refers to medicine quite close in function and structure to a biologic medicine. They have tremendous potential to provide efficiencies and enhance patient treatment access. Several companies have made strategic developments to leverage their potential. For instance, Evonik, a Germany-based company, augmented its production capacity by obtaining SurModics in 2021, focusing on controlled-release parenteral applications.

In addition, Evonik also acquired complementary technologies, including Boehringer Ingelheim's RESOMER platform, to expand its capability in the market. Likewise, WuXi Biologics declared the launch of WuXi Vaccines, which would be a joint venture along with Shanghai Hile Bio-Technology Co., Ltd. In 2019. The companies forayed into the tactical partnership wherein WuXi Vaccines would be tasked to build a dedicated facility and deliver commercial products for the global market. Thus, the biopharmaceutical industry has observed a novel class of therapeutics exhibiting significant potential in new treatments in diabetes, oncology, and other disease areas. These factors are contributing to the growth of the global pharmaceutical drug delivery systems market.

Restraints

Prevalence in Instances of needlestick injuries

Needlestick injuries are one of the gravest and most serious health and safety threats. However, the instances of such instances are not very rare. According to the Occupational Safety and Health Administration (OSHA) estimates, approximately 5.6 million workers in the United States face the risk of exposure to blood-borne pathogens as a consequence of needlestick injuries. Moreover, PharmaJet states that about 600,000 to 800,000 needlestick injuries are reported annually in the United States. In the same way, Becton, Dickinson, and Company claimed that over 1 million needlestick injuries are reported in Europe each year. Thus, the high risk of needlestick injuries and resulting consequences acts as an impeding agent for the growth of the global pharmaceuticals drug delivery systems market.

Impact of COVID-19 on the Global Pharmaceutical Drug Delivery Market

The global pharmaceutical drug delivery market was substantially impacted due to COVID-19 in 2020 in different ways. During the initial phase of the pandemic, the fear of becoming infected by coronavirus cast a greater influence on the pharmaceutical medication industry than the actual cases of Covid-19. Multivitamins and antivirals were the most popular medications that were stocked, owing to widespread concern among patients with immunodeficiency illnesses. However, lockdown measures were implemented due to the COVID-19 pandemic, thus prohibiting patient movement and probable identification.

Moreover, the surge in the COVID cases resulted in overburdening the of healthcare institutions. Patients undergoing certain treatments experienced a remarkably long turnaround time due to the COVID 19 outbreak. All of the healthcare sector's resources were concentrated on dealing with Covid-19 instances, resulting in a consequent decline in sales of medications for more serious conditions. After a few months, when it became clear that some other disorders could amplify the effects of the Covid-19 outcome, pharmaceutical items in all categories were resurrected to some extent.

Global Pharmaceutical Drug Delivery Market – By Route of administration

The pharmaceutical drug delivery market is segmented into the oral drug delivery market, injectable drug delivery market, topical drug delivery market, ocular drug delivery market, nasal drug delivery market, transmucosal drug delivery market, and other drug delivery markets. Amidst the segmentation, the oral drug delivery segment dominated the market with a considerable market share in 2021.

Oral drug delivery enjoys the greatest consumer base. On the other hand, injectable medication administration is also deployed by medical practitioners for an extensive range of pharmaceutical drugs. Thus, both of these product categories are the most common ones to be offered by pharmaceutical companies. Moreover, the ocular and pulmonary drug delivery segments are also gaining significance owing to the emergence and advancement of new treatment approaches in the field of nasal drug delivery, transmucosal drug delivery, as well as implantable drug systems.

Global Pharmaceutical Drug Delivery Market- Regional Insights                    

In terms of the regional analysis, the global pharmaceutical drug delivery market can be segmented into Middle East & Africa, Latin America, Asia Pacific, Europe, and North America. Amidst the segmentation, North America dominated the pharmaceutical drug delivery market in 2021 owing to the intensifying prevalence of chronic diseases, including cancer, diabetes, and respiratory allergies, along with increasing patient compliance to advanced drug delivery technologies.

Moreover, the presence of a great number of prominent players in North America is responsible for the high market share of the region in the global pharmaceutical drug delivery market.

 

Competitive Landscape

Many local, regional, and global vendors characterize the global pharmaceutical drug delivery market. The key players operating in the global pharmaceutical drug delivery market are Novartis International AG, Pfizer INC, Johnson & Johnson, Hoffmann-LA Roche AG, Becton, Dickinson and Company, GlaxoSmithKline PLC, Merck & Co., INC, Sanofi, Bayer AG, 3M, Antares Pharma, INC, Amgen, INC, Abbvie INC, Genmab A/S, Gilead Sciences, INC, Boehringer Ingelheim, AstraZeneca PLC, Eli Lilly and Company, Teva Pharmaceutical Industries LTD and other prominent players.

The players maintain their dominance in the market by investing in research and development activities, integrating the latest and advanced technologies into their products, and launching improved customer outcomes.

 

Recent Developments

• December 2021:  Gerresheimer AG signed an agreement with American Biotech to develop a novel pump to deliver a drug for the treatment of orphan diseases through parenteral administration. This agreement is an essential milestone for Gerresheimer AG in becoming one of the foremost solution providers for innovative medical devices.

 

• July 2021: Johnson & Johnson got approval from the FDA for DARZALEX, a daratumumab drug formulated into a subcutaneous Route to reduce treatment time for multiple myeloma indications.

 

Scope of Report:

 

Attribute	Details
Years Considered	Historical data – 2018-2021
	Base Year – 2021
	Forecast – 2022 – 2028
Facts Covered	Revenue in USD Million
Market Coverage	United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Saudi Arabia, United Arab Emirates, South Africa
Product/Service Segmentation	By route of administration, by application and by region
Key Players	The key players operating in the global pharmaceutical drug delivery market are Novartis International AG, Pfizer INC, Johnson & Johnson, Hoffmann-LA Roche AG, Becton, Dickinson and Company, GlaxoSmithKline PLC, Merck & Co., INC, Sanofi, Bayer AG, 3M, Antares Pharma, INC, Amgen, INC, Abbvie INC, Genmab A/S, Gilead Sciences, INC, Boehringer Ingelheim, AstraZeneca PLC, Eli Lilly and Company, Teva Pharmaceutical Industries LTD and other prominent players.

     

By Route Of Administration

• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Nasal Drug Delivery
• Transmucosal Drug Delivery
• Other Drug Delivery

By Application

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Diseases
• Auto Immune Diseases
• Other

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

 

Research Framework

1. 1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Research Methodology
   1. Qualitative Research
      1. Primary & Secondary Research
   2. Quantitative Research
   3. Market Breakdown & Data Triangulation
      1. Secondary Research
      2. Primary Research
   4. Breakdown of Primary Research Respondents, By Region
   5. Assumption & Limitation
3. Executive Summary
4. Global Pharmaceutical Drug Delivery Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   3. Technological Advancement/Recent Development
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
5. Global Pharmaceutical Drug Delivery Market Overview
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Route Of Administration
         1. Oral Drug Delivery
         2. Injectable Drug Delivery
         3. Topical Drug Delivery
         4. Ocular Drug Delivery
         5. Nasal Drug Delivery
         6. Transmucosal Drug Delivery
         7. Implantable Drug Delivery
         8. Other Drug Delivery
      2. By Application
         1. Infectious Diseases
         2. Cancer
         3. Cardiovascular Diseases
         4. Diabetes
         5. Respiratory Diseases
         6. Central Nervous System Diseases
         7. Auto Immune Diseases
         8. Other
      3. By Region
         1. North America
         2. Europe
         3. The Asia Pacific
         4. Latin America
         5. The Middle East and Africa
6. North America Pharmaceutical Drug Delivery Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Route Of Administration
      2. By Application
      3. By Country
         1. United States
         2. Canada
7. Europe Pharmaceutical Drug Delivery Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Route Of Administration
      2. By Application
      3. By Country
         1. Germany
         2. United Kingdom
         3. Italy
         4. France
         5. Spain
         6. Rest of Europe
8. The Asia Pacific Pharmaceutical Drug Delivery Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Route Of Administration
      2. By Application
      3. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Rest of Asia Pacific
9. Latin America Pharmaceutical Drug Delivery Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Route Of Administration
      2. By Application
      3. By Country
         1. Brazil
         2. Mexico
         3. Rest of Latin America
10. The Middle East & Africa Pharmaceutical Drug Delivery Market
    1. Market Size & Forecast by Value, 2018-2028
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Route Of Administration
       2. By Application
       3. By Country
          1. Saudi Arabia
          2. UAE
          3. South Africa
          4. Rest of Middle East & Africa
11. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Merger, Acquisition, Partnership.)
12. Impact of Covid-19 on Global Pharmaceutical Drug Delivery Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
    1. Novartis International AG
    2. Pfizer INC
    3. Johnson & Johnson
    4. Hoffmann-LA Roche AG
    5. Becton, Dickinson and Company
    6. GlaxoSmithKline PLC
    7. Merck & Co., INC
    8. Sanofi
    9. Bayer AG
    10. 3M
    11. Antares Pharma, INC
    12. Amgen, INC
    13. AbbVie INC
    14. Genmab A/S
    15. Gilead Sciences, INC
    16. Boehringer Ingelheim
    17. AstraZeneca PLC
    18. Eli Lilly and Company
14. Key Strategic Recommendations

 

*Financial information in case of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

List Of Figures

 

Figure 1: Global Pharmaceutical Drug Delivery Market Segmentation

Figure 2: Global Pharmaceutical Drug Delivery Industry Value Chain Analysis

Figure 3: Global Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 4: Global Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 5: Global Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 6: Global Pharmaceutical Drug Delivery Market Share (%), By Region, By Value, 2018-2028

Figure 7: North America Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 8: North America Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 9: North America Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 10: North America Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028 

Figure 11: Europe Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 12: Europe Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 13: Europe Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 14: Europe Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028

Figure 15: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 16: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 17: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 18: The Asia-Pacific Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028

Figure 19: Latin America Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 20: Latin America Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 21: Latin America Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 22: Latin America Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028

Figure 23: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Value (USD Million), 2018-2028

Figure 24: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Route Of Administration, By Value, 2018-2028

Figure 25: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Application, By Value, 2018-2028

Figure 26: The Middle East & Africa Pharmaceutical Drug Delivery Market Share (%), By Country, By Value, 2018-2028

Figure 27: Global Pharmaceutical Drug Delivery Market Share Analysis, 2021

 

List Of Tables

 

Table 1: Global Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 2: Global Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 3: Global Pharmaceutical Drug Delivery Market Size. By Region, By Value (USD Million), 2018-2028

Table 4: North America Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 5: North America Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 6: 28 North America Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028 

Table 7: Europe Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 8: Europe Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 9: 40 Europe Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028 

Table 10: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 11: The Asia-Pacific Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 12: 52 The Asia-Pacific Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028 

Table 13: Latin America Pharmaceutical Drug Delivery Market Size, By Route Of Administration, By Value (USD Million), 2018-2028

Table 14: Latin America Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 15: Latin America Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028 

Table 16: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 17: The Middle East & Africa Pharmaceutical Drug Delivery Market Size, By Application, By Value (USD Million), 2018-2028

Table 18: 76 The Middle East & Africa Pharmaceutical Drug Delivery Market Size (USD Million), By Country, By Value 2018-2028 

Table 19: List of Key Players and Their Offerings

Table 20: Competitive Benchmarking, by Operating Parameters

Table 21        Novartis International AG Company Overview               

Table 22        Novartis International AG Financial Overview                

Table 23        Pfizer INC Company Overview                

Table 24        Pfizer INC Financial Overview                 

Table 25        Hoffmann-LA Roche AG Company Overview                 

Table 26        Hoffmann-LA Roche AG Financial Overview         

Table 27        Becton, Dickinson and Company Overview         

Table 28        Becton, Dickinson and Company Financial Overview                

Table 29        Merck & Co., INC Company Overview                

Table 30        Merck & Co., INC Financial Overview                 

Table 31        Bayer AG Company Overview                 

Table 32        Bayer AG Financial Overview                  

Table 33        3M Company Overview                

Table 34        3M Financial Overview                 

Table 35        Antares Pharma, INC Company Overview           

Table 36        Antares Pharma, INC Financial Overview            

Table 37        Amgen, INC Company Overview             

Table 38        Amgen, INC Financial Overview              

Table 39        AbbVie INC Company Overview              

Table 40        AbbVie INC Financial Overview               

Table 41        Genmab A/S Company Overview             

Table 42        Genmab A/S Financial Overview              

Table 43        Gilead Sciences, INC Company Overview            

Table 44        Gilead Sciences, INC Financial Overview            

Table 45        Boehringer Ingelheim Company Overview          

Table 46        Boehringer Ingelheim Financial Overview           

Table 47        AstraZeneca PLC Company Overview                 

Table 48        AstraZeneca PLC Financial Overview                  

Table 49        Eli Lilly and Company Overview              

Table 50        Eli Lilly and Company Financial Overview  

Table 51        GlaxoSmithKline PLC Company Overview  

Table 52        GlaxoSmithKline PLC Company Financial Overview